Paraneoplastic Autoimmune Multiorgan Syndrome: Diagnostic Lessons for Pediatricians.

PediatricsNov 1, 2026

Bilade Cherqaoui, Léa Jaume, Gudrun Schleiermacher et al.

✦ AI-curated · Sources linked

Case in brief

An 11-year-old boy developed subacute erythroblastopenia, followed by polymorphic mucocutaneous findings, severe myositis with a dermatomyositis-like phenotype, and mild hepatitis. Progressive lymphadenopathy eventually led to diagnosis of T-lymphoblastic lymphoma associated with paraneoplastic autoimmune multiorgan syndrome. The syndrome reached remission with a Janus kinase inhibitor in addition to antitumor therapy.

What made this case unusual

The lymphoma diagnosis was delayed as the presentation evolved from erythroblastopenia to a multisystem immune-mediated syndrome resembling juvenile dermatomyositis, with mucosal and hematologic abnormalities.

Diagnostic / clinical pearl

A dermatomyositis-like presentation with atypical hematologic or mucosal findings should prompt consideration of a paraneoplastic process and early collaboration with oncology.

Why it matters

In this case, remission of the paraneoplastic syndrome required immunomodulatory treatment in addition to antitumor therapy.

Source

Published in Pediatrics. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Pediatrics

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.